Last Price$13.23.4%
Market Cap$963.9M
221.9%
Peers median - (2.4%)
31.5%
Peers median - 4.1%
33.0%
Peers median - 112.5%
188.5%
Peers median - 10.0%
Competing with IRS
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$963.9M | 6.7 | $16.6 25.0% undervalued | 104.3% | ARS 320.6B | ARS 101.1B | 221.9% | 31.5% | 64.1% | 188.5% | 33.0% | |
$136.2B | 6.3 | $164.4 21.2% overvalued | 6.4% | $38.5B | $4,933.0M | 5.0% | 12.8% | 38.3% | 14.9% | 111.5% | |
$79.9B | 6.5 | $87.9 40.4% overvalued | 91.9% | $26.6B | $638.0M | (18.7%) | 2.4% | 42.3% | 21.3% | 339.2% | |
$6,405.8M | 7.6 | $296.1 7.7% overvalued | 49.9% | $4,075.0M | $493.2M | (2.4%) | 12.1% | 30.4% | 15.5% | 8.6% | |
$4,283.5M | 4.2 | $23.1 158.5% undervalued | (36.7%) | $9,608.0M | $552.0M | (18.4%) | 5.7% | 7.2% | 0.3% | 147.3% | |
$3,428.6M | 5.0 | $13.3 20.2% overvalued | 37.1% | $3,847.4M | ($22.8M) | (22.5%) | (0.6%) | 24.5% | 4.1% | 85.2% | |
$3,154.0M | 7.0 | $97.2 40.8% undervalued | 3.2% | $2,612.7M | $305.8M | (2.5%) | 11.7% | 40.7% | 16.7% | 83.2% | |
$1,669.9M | 5.9 | $122.7 447.9% undervalued | 8.3% | $46.9B | ($1,024.6M) | (16.8%) | (2.2%) | 11.8% | 5.0% | 214.6% | |
$1,469.3M | 5.7 | $32.7 65.8% undervalued | (14.6%) | $2,198.2M | ($102.1M) | 6.8% | (4.6%) | 44.3% | 5.2% | 113.5% | |
$1,057.3M | 7.6 | $155.2 275.2% undervalued | 7.5% | $2,025.3M | $312.5M | 6.3% | 15.4% | 54.6% | 68.1% | 14.7% | |
$715.6M | 4.7 | $37.0 60.9% undervalued | (20.7%) | $1,747.6M | $40.9M | 11.7% | 2.3% | 29.5% | 0.2% | 211.2% |
Compare IRS Valuation Multiples with Peers
LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
General
Valuation Multiple
Financial metrics
Company name
EV/Revenue
Revenue growth
EBITDA margin
Net Income margin
IRSA Inversiones y Representaciones Sociedad AnónimaIRS
N/A
26.7%
N/A
(8.9%)
Median Peer Set
1.3x
(3.5%)
0.0%
8.0%
Brookfield Business Partners L.P.BBU
0.6x
(7.8%)
37.4%
0.9%
Compass DiversifiedCODI
1.4x
6.8%
(90.7%)
0.6%
Griffon CorporationGFF
1.2x
(2.3%)
196.0%
8.0%
Honeywell International Inc.HON
4.0x
5.0%
2.7%
14.8%
Icahn Enterprises L.P.IEP
0.6x
(22.4%)
(45.7%)
(4.8%)
Matthews International CorporationMATW
0.9x
(4.5%)
N/A
(3.3%)
MDU Resources Group, Inc.MDU
1.5x
(62.3%)
(32.4%)
16.0%
3M CompanyMMM
3.2x
(24.8%)
N/A
17.0%
Steel Partners Holdings L.P.SPLP
N/A
12.4%
(15.7%)
7.9%
Valmont Industries, Inc.VMI
1.6x
(2.4%)
152.7%
8.5%
Compare IRS Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does IRSA Inversiones y Representaciones Sociedad Anónima (IRS) revenue growth compare to peers and the industry?
IRSA Inversiones y Representaciones Sociedad Anónima (IRS) revenue growth is 221.9%, compared to the peers' median of (2.4%).
2. How does IRSA Inversiones y Representaciones Sociedad Anónima (IRS) Free Cash Flow (FCF) margin compare to peers and the industry?
IRSA Inversiones y Representaciones Sociedad Anónima (IRS) FCF margin is 31.5%, compared to the peers' median of 4.1%.
3. How does IRSA Inversiones y Representaciones Sociedad Anónima (IRS) Total Debt to Equity ratio compare to peers and the industry?
IRSA Inversiones y Representaciones Sociedad Anónima (IRS) Total Debt to Equity ratio is 33.0%, compared to the peers' median of 112.5%.
4. How does IRSA Inversiones y Representaciones Sociedad Anónima (IRS) ROIC (Return on Invested Capital) compare to peers and the industry?
IRSA Inversiones y Representaciones Sociedad Anónima (IRS) ROIC is 188.5%, compared to the peers' median of 10.0%.